EverProX(SZ:300548) Zheng Quan Zhi Xing·2025-07-21 16:13Core Viewpoint - The company has announced adjustments to the stock option exercise price and the grant price of restricted stock as part of its incentive plans, which were approved by the board and supervisory committee [1][8]. Group 1: 2021 Stock Option Incentive Plan - The board approved the adjustment of the stock option exercise price for the 2021 incentive plan, with the adjusted exercise prices being 20.18 RMB per share for the first grant and 21.02 RMB per share for reserved grants [6][7]. - The adjustments were made following the company's annual equity distribution, where shareholders received 0.8 RMB per 10 shares [6][7]. - The adjustments comply with relevant regulations and have been reviewed and approved by the supervisory committee [8]. Group 2: 2024 Restricted Stock Incentive Plan - The company has also adjusted the grant price for the second category of restricted stock under the 2024 incentive plan, with the adjusted price being 13.13 RMB per share [7]. - The adjustments were made in accordance with the company's annual equity distribution and comply with the relevant regulations [8]. - The supervisory committee has agreed that the adjustments align with the management measures for stock incentives [8]. Group 3: Legal Opinions - Legal opinions from Guohao Law Firm and Zhonglun Law Firm confirm that the adjustments have received the necessary approvals and comply with the Company Law, Securities Law, and relevant regulations [8][9]. - The company has fulfilled its disclosure obligations regarding the adjustments and will continue to comply with ongoing disclosure requirements [8].